Page last updated: 2024-10-26

donepezil and Hyperoxia

donepezil has been researched along with Hyperoxia in 1 studies

Donepezil: An indan and piperidine derivative that acts as a selective and reversible inhibitor of ACETYLCHOLINESTERASE. Donepezil is highly selective for the central nervous system and is used in the management of mild to moderate DEMENTIA in ALZHEIMER DISEASE.
donepezil : A racemate comprising equimolar amounts of (R)- and (S)-donepezil. A centrally acting reversible acetylcholinesterase inhibitor, its main therapeutic use is in the treatment of Alzheimer's disease where it is used to increase cortical acetylcholine.
2-[(1-benzylpiperidin-4-yl)methyl]-5,6-dimethoxyindan-1-one : A member of the class of indanones that is 5,6-dimethoxyindan-1-one which is substituted at position 2 by an (N-benzylpiperidin-4-yl)methyl group.

Hyperoxia: An abnormal increase in the amount of oxygen in the tissues and organs.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sifringer, M1
Bendix, I1
von Haefen, C1
Endesfelder, S1
Kalb, A1
Bührer, C1
Felderhoff-Mueser, U1
Spies, CD1

Other Studies

1 other study available for donepezil and Hyperoxia

ArticleYear
Oxygen toxicity is reduced by acetylcholinesterase inhibition in the developing rat brain.
    Developmental neuroscience, 2013, Volume: 35, Issue:2-3

    Topics: Animals; Animals, Newborn; Blotting, Western; Brain; Cholinesterase Inhibitors; Disease Models, Anim

2013